| BioCyc:HUMAN_PWY-5453 |
methylglyoxal degradation III |
| BioCyc:HUMAN_PWY-6307 |
tryptophan degradation via tryptamine |
| BioCyc:HUMAN_PWY66-401 |
superpathway of tryptophan utilization |
| BioCyc:META_PWY-6307 |
L-tryptophan degradation X (mammalian, via tryptamine) |
| BioCyc:META_PWY-5525 |
D-glucuronate degradation I |
| BioCyc:META_PWY3DJ-35471 |
L-ascorbate biosynthesis IV |
| BioCyc:META_PWY-6491 |
D-galacturonate degradation III |
| BioCyc:META_PWY-7466 |
acetone degradation III (to propane-1,2-diol) |
| BioCyc:META_PWY-6516 |
superpathway of microbial D-galacturonate and D-glucuronate degradation |
| BioCyc:META_PWY-5453 |
methylglyoxal degradation III |
| BioCyc:MOUSE_PWY3DJ-35471 |
L-ascorbate biosynthesis VI |
| BioCyc:MOUSE_PWY-5525 |
D-glucuronate degradation I |
| Reactome:R-BTA-1430728 |
Metabolism |
| Reactome:R-BTA-5661270 |
Formation of xylulose-5-phosphate |
| Reactome:R-BTA-156590 |
Glutathione conjugation |
| Reactome:R-DME-71387 |
Carbohydrate metabolism |
| Reactome:R-DME-5652084 |
Fructose metabolism |
| Reactome:R-HSA-5661270 |
Formation of xylulose-5-phosphate |
| Reactome:R-HSA-211859 |
Biological oxidations |
| Reactome:R-MMU-1430728 |
Metabolism |
| Reactome:R-MMU-5661270 |
Formation of xylulose-5-phosphate |
| Reactome:R-MMU-556833 |
Metabolism of lipids |
| Reactome:R-MMU-8957322 |
Metabolism of steroids |
| Reactome:R-MMU-196108 |
Pregnenolone biosynthesis |
| Reactome:R-MMU-211859 |
Biological oxidations |
| Reactome:R-RNO-196071 |
Metabolism of steroid hormones |
| Reactome:R-RNO-156590 |
Glutathione conjugation |
| Reactome:R-BTA-211859 |
Biological oxidations |
| Reactome:R-DME-1430728 |
Metabolism |
| Reactome:R-DME-196108 |
Pregnenolone biosynthesis |
| Reactome:R-HSA-71387 |
Carbohydrate metabolism |
| Reactome:R-HSA-556833 |
Metabolism of lipids |
| Reactome:R-HSA-196108 |
Pregnenolone biosynthesis |
| Reactome:R-HSA-156580 |
Phase II - Conjugation of compounds |
| Reactome:R-MMU-196071 |
Metabolism of steroid hormones |
| Reactome:R-MMU-156580 |
Phase II - Conjugation of compounds |
| Reactome:R-RNO-5652227 |
Fructose biosynthesis |
| Reactome:R-RNO-211859 |
Biological oxidations |
| Reactome:R-BTA-71387 |
Carbohydrate metabolism |
| Reactome:R-DME-5652227 |
Fructose biosynthesis |
| Reactome:R-DME-8957322 |
Metabolism of steroids |
| Reactome:R-HSA-5652084 |
Fructose metabolism |
| Reactome:R-HSA-70370 |
Galactose catabolism |
| Reactome:R-HSA-156590 |
Glutathione conjugation |
| Reactome:R-MMU-71387 |
Carbohydrate metabolism |
| Reactome:R-MMU-5652084 |
Fructose metabolism |
| Reactome:R-MMU-156590 |
Glutathione conjugation |
| Reactome:R-RNO-1430728 |
Metabolism |
| Reactome:R-RNO-5661270 |
Formation of xylulose-5-phosphate |
| Reactome:R-RNO-556833 |
Metabolism of lipids |
| Reactome:R-RNO-8957322 |
Metabolism of steroids |
| Reactome:R-RNO-196108 |
Pregnenolone biosynthesis |
| Reactome:R-BTA-156580 |
Phase II - Conjugation of compounds |
| Reactome:R-DME-556833 |
Metabolism of lipids |
| Reactome:R-DME-196071 |
Metabolism of steroid hormones |
| Reactome:R-HSA-1430728 |
Metabolism |
| Reactome:R-HSA-5652227 |
Fructose biosynthesis |
| Reactome:R-HSA-8957322 |
Metabolism of steroids |
| Reactome:R-HSA-196071 |
Metabolism of steroid hormones |
| Reactome:R-MMU-5652227 |
Fructose biosynthesis |
| Reactome:R-RNO-71387 |
Carbohydrate metabolism |
| Reactome:R-RNO-5652084 |
Fructose metabolism |
| Reactome:R-RNO-156580 |
Phase II - Conjugation of compounds |
| PathBank:SMP0120706 |
Glycerol Kinase Deficiency |
| PathBank:SMP0120726 |
Leigh Syndrome |
| PathBank:SMP0120774 |
Hyperphenylalaninemia Due to DHPR-Deficiency |
| PathBank:SMP0120814 |
Familial Lipoprotein Lipase Deficiency |
| PathBank:SMP0120842 |
Pyruvate Kinase Deficiency |
| PathBank:SMP0120468 |
Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0120629 |
Aromatase Deficiency |
| PathBank:SMP0120641 |
Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0120649 |
Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0000039 |
Glycerolipid Metabolism |
| PathBank:SMP0000064 |
Fructose and Mannose Degradation |
| PathBank:SMP0000334 |
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency) |
| PathBank:SMP0000005 |
Pterine Biosynthesis |
| PathBank:SMP0000488 |
Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps) |
| PathBank:SMP0087197 |
Fructose and Mannose Degradation |
| PathBank:SMP0087225 |
Galactose Metabolism |
| PathBank:SMP0087250 |
Pterine Biosynthesis |
| PathBank:SMP0120753 |
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency) |
| PathBank:SMP0120773 |
Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps) |
| PathBank:SMP0120813 |
D-Glyceric Acidura |
| PathBank:SMP0120841 |
Primary Hyperoxaluria II, PH2 |
| PathBank:SMP0120451 |
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0120463 |
Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0120467 |
Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0120495 |
Zellweger Syndrome |
| PathBank:SMP0120640 |
21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000043 |
Galactose Metabolism |
| PathBank:SMP0000196 |
Leigh Syndrome |
| PathBank:SMP0000182 |
Galactosemia |
| PathBank:SMP0000187 |
Glycerol Kinase Deficiency |
| PathBank:SMP0000487 |
Hyperphenylalaninemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency |
| PathBank:SMP0000491 |
Sepiapterin Reductase Deficiency |
| PathBank:SMP0000559 |
Pyruvate Kinase Deficiency |
| PathBank:SMP0000725 |
Fructose Intolerance, Hereditary |
| PathBank:SMP0087325 |
Pyruvate Metabolism |
| PathBank:SMP0063672 |
Steroidogenesis |
| PathBank:SMP0120652 |
27-Hydroxylase Deficiency |
| PathBank:SMP0120772 |
Hyperphenylalaninemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency |
| PathBank:SMP0120776 |
Sepiapterin Reductase Deficiency |
| PathBank:SMP0120844 |
Fructosuria |
| PathBank:SMP0120876 |
Fructose Intolerance, Hereditary |
| PathBank:SMP0120437 |
17-beta Hydroxysteroid Dehydrogenase III Deficiency |
| PathBank:SMP0120477 |
Familial Hypercholanemia (FHCA) |
| PathBank:SMP0120630 |
17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0120642 |
Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0120650 |
3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0000212 |
Pyruvate Dehydrogenase Complex Deficiency |
| PathBank:SMP0000489 |
Hyperphenylalaninemia Due to DHPR-Deficiency |
| PathBank:SMP0000529 |
D-Glyceric Acidura |
| PathBank:SMP0000561 |
Fructosuria |
| PathBank:SMP0000650 |
Doxorubicin Metabolism Pathway |
| PathBank:SMP0087231 |
Pyruvate Metabolism |
| PathBank:SMP0087296 |
Fructose and Mannose Degradation |
| PathBank:SMP0087320 |
Galactose Metabolism |
| PathBank:SMP0087324 |
Glycerolipid Metabolism |
| PathBank:SMP0063594 |
Androgen and Estrogen Metabolism |
| PathBank:SMP0063688 |
Androstenedione Metabolism |
| PathBank:SMP0063817 |
Ascorbate Biosynthesis |
| PathBank:SMP0120699 |
Galactosemia |
| PathBank:SMP0120751 |
Pyruvate Dehydrogenase Complex Deficiency |
| PathBank:SMP0120771 |
DOPA-Responsive Dystonia |
| PathBank:SMP0120775 |
Segawa Syndrome |
| PathBank:SMP0120450 |
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0120470 |
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0120639 |
11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0000060 |
Pyruvate Metabolism |
| PathBank:SMP0000486 |
DOPA-Responsive Dystonia |
| PathBank:SMP0000490 |
Segawa Syndrome |
| PathBank:SMP0000530 |
Familial Lipoprotein Lipase Deficiency |
| PathBank:SMP0000558 |
Primary Hyperoxaluria II, PH2 |
| PathBank:SMP0087230 |
Glycerolipid Metabolism |
| PathBank:SMP0087343 |
Pterine Biosynthesis |
| PathBank:SMP0063601 |
Bile Acid Biosynthesis |